Latest Articles
Lenvatinib Dose Reductions Help Sustain Therapy in Endometrial Cancer - CancerNetwork
Lenvatinib Dose Reductions Help Sustain Therapy in Endometrial Cancer CancerNetwork
Published: Aug. 25, 2026, 8:07 p.m.
NIH funds study of forever chemicals’ liver and endometrial cancer risks - Bioengineer.org
NIH funds study of forever chemicals’ liver and endometrial cancer risks Bioengineer.org
Published: Aug. 25, 2026, 6 p.m.
NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers - News-Medical
NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers News-Medical
Published: Aug. 25, 2026, 5:33 p.m.
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer - CancerNetwork
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer CancerNetwork
Published: Aug. 24, 2026, 8:05 p.m.
Preoperative Weight-Loss Program Shows Feasibility Before Endometrial Cancer Surgery - The ASCO Post
Preoperative Weight-Loss Program Shows Feasibility Before Endometrial Cancer Surgery The ASCO Post
Published: Aug. 24, 2026, 4:57 p.m.
Platinum-Free Interval Does Not Predict IO Response in Endometrial Cancer - CancerNetwork
Platinum-Free Interval Does Not Predict IO Response in Endometrial Cancer CancerNetwork
Published: Aug. 23, 2026, 2:05 p.m.
OncLive Weekly News Quiz (8/21/2026): Did You Miss Key Lung, Bladder, and Endometrial Cancer Updates? - OncLive
OncLive Weekly News Quiz (8/21/2026): Did You Miss Key Lung, Bladder, and Endometrial Cancer Updates? OncLive
Published: Aug. 21, 2026, 1:02 p.m.
Mayne Pharma to Present IMVEXXY® Endometrial Cancer Study at 2026 ISPE Annual Meeting - Kalkine
Mayne Pharma to Present IMVEXXY® Endometrial Cancer Study at 2026 ISPE Annual Meeting Kalkine
Published: Aug. 19, 2026, 11:15 p.m.
FDA Grants Fast Track Designation to Piktor in Endometrial Cancer - Targeted Oncology
FDA Grants Fast Track Designation to Piktor in Endometrial Cancer Targeted Oncology
Published: Aug. 18, 2026, 10:06 p.m.
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer - AllSci
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer AllSci
Published: Aug. 18, 2026, 2:27 p.m.
Link copied to clipboard!